Skip to main content
. 2024 Apr 3;8(6):560–567. doi: 10.22603/ssrr.2024-0030

Table 4.

Treatment and Progress.

Lower N=139 Mid N=312 p-value
Surgical treatment 123 (88%) 254 (81%) 0.061
Conversion to surgery 25 (18%) 43 (14%) 0.25
Surgical procedure 0.47
Posterior 110 (90%) 218 (86%)
Others 5 (4%) 13 (5%)
Anterior 7 (6%) 23 (9%)
Others 5 (4%) 13 (5%)
Decompression 43 (35%) 117 (46%) 0.047
Intraoperative complications 2 (1%) 9 (3%) 0.52
Dura tear 1 4
Neurological 1 3
VA injury 0 1
Cardiac arrest due to bleeding 0 1
Complications 57 (41%) 132 (42%) 0.80
Death 6 (4%) 20 (6%) 0.38
Deep SSI 1 (1%) 4 (1%) >0.99
Pneumonia 19 (14%) 46 (15%) 0.76
Respiratory failure 12 (9%) 52 (17%) 0.024
Tracheostomy 3 (2%) 17 (5%) 0.12
Dysphagia 15 (11%) 45 (14%) 0.29
DVT 5 (4%) 2 (1%) 0.031
PE 0 (0%) 1 (0%) >0.99
Ambulation, 6 months 0.54
Walk w/o assistance 76 (72%) 154 (66%)
Walk w/ assistance 10 (10%) 30 (13%)
Nonambulatory 19 (18%) 49 (21%)
Unknown 34 79
AIS, 6 months 0.76
A 8 (12%) 15 (10%)
B 3 (4%) 8 (5%)
C 9 (13%) 18 (12%)
D 24 (36%) 66 (45%)
E 23 (34%) 41 (28%)
Unknown 72 164

VA, vertebral artery; SSI, surgical site infection; DVT, deep vein thrombosis; PE, pulmonary embolism; AIS, ASIA (American Spinal Injury Association) impairment scale